Ads
related to: Keytruda- What Is KEYTRUDA?
Learn About What KEYTRUDA Is & How
It May Help Eligible Patients.
- Side Effects
Learn About Possible Side Effects
at the Official Patient Site.
- Treatment Options
Learn About Treatment
Options With KEYTRUDA.
- Clinical Trial Results
See Clinical Trial Results
at the Official Site.
- Taking KEYTRUDA?
Learn What to Expect When
Taking KEYTRUDA.
- Resources and FAQ
Find Additional Patient Information
& Resources About KEYTRUDA Here.
- What Is KEYTRUDA?
Search results
Lack of insurance may prevent Americans from accessing best cancer drugs
United Press International via Yahoo News· 17 hours agoA cutting-edge class of drugs is saving and extending the lives of cancer patients. But the drugs,...
Merck is spending $3 billion on an eye drug developer as it braces to lose a key cancer patent
Quartz· 6 days agoPharma giant Merck said on Wednesday that it is acquiring the privately-held eye drug developer...
‘I can’t explain why’: Does this dog dewormer cure cancer? These Facebook groups say yes
The Daily Dot· 5 days agoThree months later, the cancer had grown. From a cattle farm in Louisiana where she’s helping a...
CNBC Daily Open: Dow drops on weak manufacturing data, GameStop soars
CNBC· 9 hours agoTraders work as a screen displays the trading information for GameStop and AMC Theatres on the floor...
Summit Therapeutics' stock surges as lung-cancer treatment vies with Merck's blockbuster
Morningstar· 5 days agoShares of Summit Therapeutics Inc. (SMMT) jumped more than 270% Thursday after the company said its experimental cancer drug outperformed Merck & Co. Inc.'s blockbuster Keytruda< ...
Summit Therapeutics sees stock soar 272% after lung cancer clinical trial - Silicon Valley Business...
The Business Journals· 4 days agoSummit (Nasdaq: SMMT) — led by the team that scored success with blood cancer drug developer...
Merck to buy eye-focused drug developer EyeBio for as much as $3 billion By Reuters
Investing.com· 6 days agoMerck said in February it was in the market for deals of up to $15 billion, and has already struck...
Summit Therapeutics stock rallies as institutional buyer loads up on shares | Invezz
Invezz· 20 hours agoSummit Therapeutics Inc (NASDAQ: SMMT) says it raised $200 million via an offer it accepted from an...
Merck stock climbs as breast cancer Phase 3 trial data meets endpoint By Investing.com
Investing.com· 7 days agoMerck & Co (MRK) announced on Tuesday that its phase 3 KEYNOTE-522 trial evaluating Keytuda...
Pharma Billionaire's Fortune More Than Doubles In A Day On Cancer Drug Trial News
Forbes· 4 days agoShares of biotech firm Summit Therapeutics more than tripled on Thursday following good news about a...
Ads
related to: Keytruda